Condition
NSAIDs
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 2 (1)
P 3 (2)
P 4 (1)
Trial Status
Recruiting2
Completed2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07102641Phase 4Recruiting
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
NCT05504265Phase 2Recruiting
Perioperative Analgesia Modes in Minimally Invasive Esophagectomy
NCT05947461Not ApplicableTerminated
Prevention of Post-ERCP Pancreatitis by Indomethacin Vs Diclofenac
NCT00241527Phase 3CompletedPrimary
Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
NCT00241553Phase 3CompletedPrimary
Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
Showing all 5 trials